Stockreport

Immuneering to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Immuneering Corporation - Class A  (IMRX) 
PDF CAMBRIDGE, Mass., April 03, 2024 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop and commercialize uni [Read more]